newsfilter
← Latest News
GlobeNewswire·

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

FREDERICK, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the "Company"), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that